Mohsen Ebraimi

Pediatrician, Assistant Professor, Neonatal and Children’s Health Research Center, Taleghani Children’s Center, Golestan University of Medical Sciences, Gorgan, Iran.

[ 1 ] - The Efficacy of Baclofen to Treat Gastroesophageal Reflux disease in Children Aged 6 Months to 12 Years: A Clinical Trial Study

Background Gastroesophageal Reflux is a physiological phenomenon, which occurs in infants, children, and normal adults. Various studies have shown that Baclofen is a potent inhibitor of lower esophageal sphincter and has beneficial effects in adult reflux disease. We aimed to evaluate the Baclofen effect in pediatric Gastroesophage...

نویسندگان همکار